{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:29:58Z","timestamp":1791030598810,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.heliyon.2024.e27175","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T21:18:30Z","timestamp":1709068710000},"page":"e27175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of potential immunotherapeutic targets and prognostic biomarkers in Graves' disease using weighted gene co-expression network analysis"],"prefix":"10.1016","volume":"10","author":[{"given":"Nianrong","family":"Mi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaolian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.heliyon.2024.e27175_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2020.101388","article-title":"Graves' disease: clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy","volume":"34","author":"Antonelli","year":"2020","journal-title":"Best Pract. Res. Clin. Endocrinol. Metabol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e27175_bib2","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s10792-019-01258-7","article-title":"Thyroid eye disease: current and potential medical management","volume":"40","author":"Pouso-Diz","year":"2020","journal-title":"Int. Ophthalmol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e27175_bib3","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s12020-017-1306-5","article-title":"Epidemiology, management and outcomes of Graves' disease-real life data","volume":"56","author":"Hussain","year":"2017","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e27175_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrendo.2018.18","article-title":"Global epidemiology of hyperthyroidism and hypothyroidism","volume":"14","author":"Taylor","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e27175_bib5","article-title":"Hyperthyroidism prevalence in China after Universal Salt Iodization","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e27175_bib6","article-title":"Influence of rapid urbanization on thyroid autoimmune disease in China","volume":"2021","author":"Chen","year":"2021","journal-title":"Internet J. Endocrinol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e27175_bib7","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1089\/thy.2022.0251","article-title":"Management of thyroid eye disease: a consensus statement by the American thyroid association and the European thyroid association","volume":"32","author":"Burch","year":"2022","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27175_bib8","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-21-0073","article-title":"2022 European thyroid association guideline for the management of pediatric Graves' disease","volume":"11","author":"Mooij","year":"2022","journal-title":"Eur. Thyroid J."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e27175_bib9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000517174","article-title":"The efficacy and short- and long-term side effects of radioactive iodine treatment in pediatric Graves' disease: a systematic review","volume":"10","author":"Lutterman","year":"2021","journal-title":"Eur. Thyroid J."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e27175_bib10","first-page":"368","article-title":"Sporadic medullary thyroid carcinoma in Graves' disease","volume":"18","author":"Semeniene","year":"2022","journal-title":"Acta Endocrinol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e27175_bib11","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1245\/s10434-012-2606-x","article-title":"What is the best definitive treatment for Graves' disease? A systematic review of the existing literature","volume":"20","author":"Genovese","year":"2013","journal-title":"Ann. Surg Oncol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27175_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/jcp-2022-208290","article-title":"Thyroid autoantibodies","volume":"76","author":"Dwivedi","year":"2023","journal-title":"J. Clin. Pathol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e27175_bib13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1055\/s-0035-1559646","article-title":"Genetics of Graves' disease: special focus on the role of TSHR gene","volume":"47","author":"Pujol-Borrell","year":"2015","journal-title":"Horm. Metab. Res."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e27175_bib14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41433-018-0285-y","article-title":"B cells in Graves' Orbitopathy: more than just a source of antibodies?","volume":"33","author":"Salvi","year":"2019","journal-title":"Eye (Lond)"},{"issue":"22","key":"10.1016\/j.heliyon.2024.e27175_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216432","article-title":"Regulatory T cells in the pathogenesis of Graves' disease","volume":"24","author":"Kustrimovic","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e27175_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fendo.2016.00021","article-title":"Dissecting the genetic susceptibility to Graves' disease in a cohort of patients of Italian origin","volume":"7","author":"Lombardi","year":"2016","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e27175_bib17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1208\/s12248-021-00642-5","article-title":"Immunogenicity risk assessment for multi-specific therapeutics","volume":"23","author":"Kroenke","year":"2021","journal-title":"AAPS J."},{"key":"10.1016\/j.heliyon.2024.e27175_bib18","article-title":"In silico immunogenicity assessment for sequences containing unnatural amino acids: a method using existing in silico algorithm infrastructure and a vision for future enhancements","volume":"2","author":"Mattei","year":"2022","journal-title":"Front Drug Discov (Lausanne)"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27175_bib19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27175_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13073-020-00783-w","article-title":"The murine Microenvironment Cell Population counter method to estimate abundance of tissue-infiltrating immune and stromal cell populations in murine samples using gene expression","volume":"12","author":"Petitprez","year":"2020","journal-title":"Genome Med."},{"issue":"14","key":"10.1016\/j.heliyon.2024.e27175_bib21","doi-asserted-by":"crossref","first-page":"i436","DOI":"10.1093\/bioinformatics\/btz363","article-title":"Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology","volume":"35","author":"Sturm","year":"2019","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27175_bib22","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol."},{"key":"10.1016\/j.heliyon.2024.e27175_bib23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-1-0716-0327-7_19","article-title":"Cell-type enrichment analysis of bulk transcriptomes using xCell","volume":"2120","author":"Aran","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.heliyon.2024.e27175_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.756560","article-title":"Identification of lncRNA and mRNA expression profile in relapsed Graves' disease","volume":"9","author":"Yao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.heliyon.2024.e27175_bib25","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3389\/fgene.2019.01142","article-title":"Identifying key genes and functionally enriched pathways in sj\u00f6gren's syndrome by weighted gene Co-expression network analysis","volume":"10","author":"Yao","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.heliyon.2024.e27175_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1048139","article-title":"Bioinformatics analysis identifies immune-related gene signatures and subtypes in diabetic nephropathy","volume":"13","author":"Lu","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27175_bib27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12935-021-01939-3","article-title":"Identification of an immune-related signature indicating the dedifferentiation of thyroid cells","volume":"21","author":"Wang","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27175_bib28","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/s13104-019-4471-1","article-title":"Shiny-Seq: advanced guided transcriptome analysis","volume":"12","author":"Sundararajan","year":"2019","journal-title":"BMC Res. Notes"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e27175_bib29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000490384","article-title":"2018 European thyroid association guideline for the management of Graves' hyperthyroidism","volume":"7","author":"Kahaly","year":"2018","journal-title":"Eur. Thyroid J."},{"issue":"1796","key":"10.1016\/j.heliyon.2024.e27175_bib30","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2019.0316","article-title":"Exploring modularity in biological networks","volume":"375","author":"Serban","year":"2020","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.heliyon.2024.e27175_bib31","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/1471-2105-13-328","article-title":"Comparison of co-expression measures: mutual information, correlation, and model based indices","volume":"13","author":"Song","year":"2012","journal-title":"BMC Bioinf."},{"issue":"D1","key":"10.1016\/j.heliyon.2024.e27175_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkw943","article-title":"DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants","volume":"45","author":"Pi\u00f1ero","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2024.e27175_bib33","series-title":"PLA1A Expression as a Diagnostic Marker of BRAF-Mutant Metastasis in Melanoma Cancer","author":"Yang","year":"2021"},{"issue":"23","key":"10.1016\/j.heliyon.2024.e27175_bib34","doi-asserted-by":"crossref","first-page":"19580","DOI":"10.18632\/oncotarget.3973","article-title":"Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition","volume":"6","author":"Khan","year":"2015","journal-title":"Oncotarget"},{"issue":"13","key":"10.1016\/j.heliyon.2024.e27175_bib35","doi-asserted-by":"crossref","first-page":"21362","DOI":"10.18632\/oncotarget.15214","article-title":"MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion","volume":"8","author":"Imani","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2024.e27175_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinf."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e27175_bib37","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/bioinformatics\/btv707","article-title":"Joint detection of copy number variations in parent-offspring trios","volume":"32","author":"Liu","year":"2016","journal-title":"Bioinformatics"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e27175_bib38","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.7150\/jca.23762","article-title":"Development of A three-gene prognostic signature for hepatitis B virus associated hepatocellular carcinoma based on integrated transcriptomic analysis","volume":"9","author":"Yang","year":"2018","journal-title":"J. Cancer"},{"issue":"1\u20133","key":"10.1016\/j.heliyon.2024.e27175_bib39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12026-012-8312-8","article-title":"Delineating the autoimmune mechanisms in Graves' disease","volume":"54","author":"Morshed","year":"2012","journal-title":"Immunol. Res."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e27175_bib40","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.4049\/jimmunol.1500183","article-title":"Graves' disease TSHR-stimulating antibodies (TSAbs) induce the activation of immature thymocytes: a clue to the riddle of TSAbs generation?","volume":"194","author":"Gimenez-Barcons","year":"2015","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e27175_bib41","first-page":"168","article-title":"Th1\/Th2 cytokines in patients with Graves' disease with or without ophthalmopathy","volume":"12","author":"Esfahanian","year":"2013","journal-title":"Iran. J. Allergy, Asthma Immunol."},{"key":"10.1016\/j.heliyon.2024.e27175_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155353","article-title":"Serum interferon levels associated with the disease activity in women with overt Graves' disease","volume":"138","author":"Cheng","year":"2021","journal-title":"Cytokine"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e27175_bib43","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-0035-1559633","article-title":"Graves' disease mechanisms: the role of stimulating, blocking, and cleavage region TSH receptor antibodies","volume":"47","author":"Morshed","year":"2015","journal-title":"Horm. Metab. Res."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e27175_bib44","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3892\/etm.2020.9282","article-title":"Comparison of two regimens for patients with thyroid-associated ophthalmopathy receiving intravenous methyl prednisolone: a single center prospective randomized trial","volume":"20","author":"Mu","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.heliyon.2024.e27175_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.648732","article-title":"Mechanisms that underly T cell immunity in Graves' orbitopathy","volume":"12","author":"Fang","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e27175_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22062903","article-title":"Incorporating machine learning into established bioinformatics frameworks","volume":"22","author":"Auslander","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e27175_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.943944","article-title":"A combined aging and immune prognostic signature predict prognosis and responsiveness to immunotherapy in melanoma","volume":"13","author":"Lv","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e27175_bib48","first-page":"326","article-title":"Novel insights into the pathological development of dyslipidemia in patients with hypothyroidism","volume":"22","author":"Su","year":"2022","journal-title":"Bosn. J. Basic Med. Sci."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e27175_bib49","article-title":"Nonalcoholic fatty liver disease and hypothyroidism: what you need to know","volume":"14","author":"Bikeyeva","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.heliyon.2024.e27175_bib50","article-title":"Genetics, epigenetics, cellular immunology, and gut microbiota: emerging links with Graves' disease","volume":"9","author":"Zhou","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.heliyon.2024.e27175_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1217253","article-title":"Current and promising therapies based on the pathogenesis of Graves' ophthalmopathy","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27175_bib52","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s11302-022-09858-2","article-title":"Purinergic signaling in thyroid disease","volume":"19","author":"Le","year":"2023","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.heliyon.2024.e27175_bib53","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/434727","article-title":"New approaches to thyroid hormones and purinergic signaling","volume":"2013","author":"Silveira","year":"2013","journal-title":"J. Thyroid Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27175_bib54","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12916-017-0939-9","article-title":"Is Graves' disease a primary immunodeficiency? New immunological perspectives on an endocrine disease","volume":"15","author":"Struja","year":"2017","journal-title":"BMC Med."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e27175_bib55","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1210\/er.2002-0020","article-title":"Current perspective on the pathogenesis of Graves' disease and ophthalmopathy","volume":"24","author":"Prabhakar","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.heliyon.2024.e27175_bib56","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3389\/fendo.2019.00709","article-title":"Orexins as novel therapeutic targets in inflammatory and neurodegenerative diseases","volume":"10","author":"Couvineau","year":"2019","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e27175_bib57","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/jsr.12143","article-title":"Narcolepsy with cataplexy and comorbid immunopathological diseases","volume":"23","author":"Mart\u00ednez-Orozco","year":"2014","journal-title":"J. Sleep Res."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e27175_bib58","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1139\/cjpp-2014-0258","article-title":"Effect of orexin-A (hypocretin-1) on hyperalgesic and cachectic manifestations of experimentally induced rheumatoid arthritis in rats","volume":"92","author":"Mohamed","year":"2014","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e27175_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/7729238","article-title":"Association of IL-1\u03b2, NLRP3, and COX-2 gene polymorphisms with autoimmune thyroid disease risk and clinical features in the Iranian population","volume":"2021","author":"Heidari","year":"2021","journal-title":"BioMed Res. Int."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e27175_bib60","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pjnns.2017.01.007","article-title":"Excessive daytime sleepiness in a patient with coexisting myotonic dystrophy type 1, myasthenia gravis and Graves' disease","volume":"51","author":"Kapica-Topczewska","year":"2017","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.heliyon.2024.e27175_bib61","article-title":"Ginsenoside Rg5 allosterically interacts with P2RY(12) and ameliorates deep venous thrombosis by counteracting neutrophil NETosis and inflammatory response","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e27175_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111273","article-title":"Diabetes and hypertension: pivotal involvement of purinergic signaling","volume":"137","author":"Reichert","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e27175_bib63","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/jth.13239","article-title":"Neutrophil elastase-deficient mice form neutrophil extracellular traps in an experimental model of deep vein thrombosis","volume":"14","author":"Martinod","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.heliyon.2024.e27175_bib64","article-title":"Acute pancreatitis: diagnosis and treatment. Drugs","volume":"vol. 82","author":"Szatmary","year":"2022"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e27175_bib65","doi-asserted-by":"crossref","first-page":"G466","DOI":"10.1152\/ajpgi.00419.2013","article-title":"Human cationic trypsinogen (PRSS1) variants and chronic pancreatitis","volume":"306","author":"N\u00e9meth","year":"2014","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e27175_bib66","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/1756-185X.13783","article-title":"P2 receptors mRNA expression profiles in macrophages from ankylosing spondylitis patients and healthy individuals","volume":"23","author":"Akhtari","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.heliyon.2024.e27175_bib67","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/7664641","article-title":"Association of polygenetic risk scores related to immunity and inflammation with hyperthyroidism risk and interactions between the polygenetic scores and dietary factors in a large cohort","volume":"2021","author":"Song","year":"2021","journal-title":"J. Thyroid Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27175_bib68","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bpsgos.2021.03.002","article-title":"Investigating pleiotropy between depression and autoimmune diseases using the UK biobank","volume":"1","author":"Glanville","year":"2021","journal-title":"Biol Psychiatry Glob Open Sci"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27175_bib69","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00423-023-03153-3","article-title":"TSH receptor autoantibody levels post-total thyroidectomy in Graves' ophthalmopathy: a meta-analysis","volume":"408","author":"Anees","year":"2023","journal-title":"Langenbeck's Arch. Surg."},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2024.e27175_bib70","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1006\/mgme.2000.3042","article-title":"Genetic determinants of Graves disease","volume":"71","author":"Chistyakov","year":"2000","journal-title":"Mol. Genet. Metabol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e27175_bib71","first-page":"209","article-title":"Thyroid hormone resistance and its management","volume":"29","author":"Rivas","year":"2016","journal-title":"SAVE Proc."},{"key":"10.1016\/j.heliyon.2024.e27175_bib72","article-title":"Emerging insights into the role of epigenetics and gut microbiome in the pathogenesis of Graves' ophthalmopathy","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e27175_bib73","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fendo.2020.00406","article-title":"Immunological drivers in Graves' disease: NK cells as a master switcher","volume":"11","author":"Gallo","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e27175_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.147013","article-title":"Association of orexin\/hypocretin receptor gene (HCRTR1) with reward sensitivity, and interaction with gender","volume":"1746","author":"Pulver","year":"2020","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e27175_bib75","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s40618-014-0228-9","article-title":"TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy","volume":"38","author":"Bufalo","year":"2015","journal-title":"J. Endocrinol. Invest."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e27175_bib76","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1055\/s-0035-1559646","article-title":"Genetics of Graves' disease: special focus on the role of TSHR gene","volume":"47","author":"Pujol-Borrell","year":"2015","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.heliyon.2024.e27175_bib77","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fendo.2017.00057","article-title":"Genetics of thyroid-stimulating hormone receptor-relevance for autoimmune thyroid disease","volume":"8","author":"Stefan","year":"2017","journal-title":"Front. Endocrinol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024032067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024032067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:45:35Z","timestamp":1769046335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024032067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":77,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2405844024032067"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27175","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of potential immunotherapeutic targets and prognostic biomarkers in Graves' disease using weighted gene co-expression network analysis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e27175"}}